Non-compliance with China’s Drug Master File (DMF) regulations can result in severe penalties, including fines, suspension of product registration, and revocation of manufacturing licenses. Companies may face import bans and reputational damage, hindering market access. Ensuring compliance is crucial to maintaining business operations and avoiding legal and financial repercussions.